Patent · US Active

In situ antigen-generating cancer vaccine

US10406216B2 · kind B2 · utility

4Cited by
45References
38Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 7, 2016
Grant dateSep 10, 2019
Priority date—
Expiry dateNov 7, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/70
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions and methods for utilizing scaffolds in cancer vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.